M11.151 Familial chondrocalcinosis, right hip

Name of the Condition

• Familial chondrocalcinosis, right hip

Summary

Familial chondrocalcinosis, right hip is a hereditary condition characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the right hip joint and surrounding tissues. This leads to inflammation, pain, and potential joint damage. It is a subtype of calcium pyrophosphate deposition disease (CPPD) with a genetic basis, specifically affecting the right hip. Diagnosis typically involves clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, right hip is caused by genetic mutations that influence calcium pyrophosphate crystal formation in the right hip’s cartilage, synovium, or periarticular structures. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Genetic predisposition (family history of chondrocalcinosis or related crystal arthropathies).
• Advanced age (increases likelihood of crystal deposition).
• Metabolic conditions affecting calcium or phosphate levels.
• Hip trauma or surgery (may trigger crystal release).
• Chronic inflammatory joint diseases.

Symptoms

• Right hip pain, swelling, and stiffness.
• Recurrent episodes of acute inflammation.
• Reduced range of motion in the right hip.
• Joint instability or deformity over time.

Diagnosis

Diagnosis of familial chondrocalcinosis, right hip involves a combination of clinical assessment, imaging studies (e.g., X-rays, MRI), and laboratory tests. Imaging may reveal characteristic crystal deposits or joint damage. Joint fluid analysis can confirm the presence of CPPD crystals. Genetic testing may be considered if a hereditary pattern is suspected.

Treatment Options

Treatment focuses on managing symptoms and preventing joint damage. Options include nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation, corticosteroid injections for acute flare-ups, and physical therapy to maintain joint function. In severe cases, surgery (e.g., joint replacement) may be necessary.

Prognosis and Follow-Up

Prognosis varies depending on the extent of joint damage and response to treatment. Early diagnosis and management can help preserve joint function. Regular follow-up with a healthcare provider is recommended to monitor symptoms, adjust treatment, and address complications.

Complications

Potential complications include chronic joint pain, progressive joint damage, osteoarthritis, and reduced mobility. Recurrent flare-ups may lead to functional impairment if not managed effectively.

Lifestyle & Prevention

Lifestyle modifications, such as maintaining a healthy weight to reduce hip stress, avoiding excessive joint strain, and staying active with low-impact exercises, may help manage symptoms. Preventive measures focus on early detection and treatment of flare-ups.

When to Seek Professional Help

Seek medical attention if you experience persistent right hip pain, swelling, or stiffness, or if symptoms worsen despite home care. Acute, severe pain or inability to bear weight on the right hip requires prompt evaluation.

Tips for Medical Coders

When coding for familial chondrocalcinosis, right hip (M11.151), ensure documentation specifies the right hip as the affected site. Verify that the condition is hereditary (familial) and not secondary to other causes. Include details of clinical findings, imaging results, or crystal identification to support the diagnosis.